Objective: Progesterone plays an important role in controlling proliferation and diferentiation of the human endometrium. Because there are two progesterone receptor isoforms (PRA and PRB), it was important to generate tools to be able to study the role of these two progesterone receptors separately.
Methods: Using stable transfection techniques, both human progesterone receptor isoforms (hPRA and hPRB) were reintroduced into a hPR-negative subclone of the well-differentiated endometrial cancer cell line Ishikawa. Several Ishikawa subcell lines were constructed, each expressing different levels of hPRA, hPRB, or hPRA and hPRB, respectively.
Results: These Ishikawa subcell lines showed a marked progesterone-induced growth inhibition with induction of apoptosis after long-term culture in the presence of hormone. Upon measuring gene regulation, a clear diference in regulation of expression of the selected genes by progesterone treatment was observed between the PRA-, PRB-, or PRA/B-expressing cell lines. Integrin β34 (ITGB4) was only regulated in PRA-expressing cells; amphiregulin was highly regulated in PRB-expressing cells; inuslin-like gwoth factor binding protein 3 (IGFBP3) was only regulated in PRBand PRA /B-expressing cells; and metallothionein 1L (MT1L) was highly regulated in PRA/B-expressing cells. Interestingly, based on literature data, these genes can be implicated in induction of apoptosis, but are modulated here in such a way that suggests induction of resistance against apoptosis.
Conclusion: Reintroduction of PRs into Ishikawa cells rescued progesterone responsiveness in these cells. Furthermore, using these human endometrial cancer subcell lines, clear and distinct functional diferences between the PR isoforms were observed.
1. Martin L, Das RM, Finn CA. The inhibition by progesterone of uterine epithelial proliferation in the mouse. J Endocrinol1973;57:549-554.
2.
2. Ehrlich CE, Young PC, Cleary RE. Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications. Am J Obstet Gynecol1981;141:539-546.
4. Rose PG. Endometrial carcinoma. N Engl J Med1996;335: 640-649.
5.
5. Kim YB, Holschneider CH, Ghosh K, Nieberg RK, Montz FJ. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature. Cancer1997;7:320-327.
6.
6. Horwitz KB, Alexander PS. In situ photolinked nuclear progesterone receptors of human breast cancer cells: Subunit molecular weights after transformation and translocation. Endocrinology1983;113:2195-2201.
7.
7. Kastner P, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P.Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J1990;9:1603-1614.
8.
8. Lessey BA, Alexander PS, Horwitz KB. The subunit structure of human breast cancer progesterone receptors: characterization by chromatography and photoaffinity labeling. Endocrinology1983;112:1267-1274.
9.
9. Hovland AR, Powell RL, Takimoto GS, Tung L, Horwitz KB. An N-terminal inhibitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors. J Biol Chem1998;272:545-560.
10.
10. Giangrande PH, Pollio G, McDonnell DP. Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor. J Biol Chem1997;272:32889-32900.
11.
11. Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW, McDonnell DP. Human progesterone receptor A form is a celland promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol1993;7:1244-1255.
12.
12. Giangrande PH, Kimbrel EA, Edwards DP, McDonnell DP. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol Cell Biol2000;20:3102-3115.
13.
13. Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, Horwitz KB. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem2002;277:5209-5218.
14.
14. Jacobsen BM, Richer JK, Schittone SA, Horwitz KB. New human breast cancer cells to study progesterone receptor isoform ratio effects and ligand-independent gene regulation. J Biol Chem2002;277:27793-27800.
15.
15. Smid-Koopman E, Blok LJ, Kuhne ECM, et al. Distinct functional differences of the human progesterone receptors A and B on gene expression and growth regulation in endometrial carcinoma cells. J Soc Gynecol Investig2003;10:49-57.
16.
16. Nishida M, Kasahara K, Oki A, Satoh T, Arai Y, Kubo T.Establishment of eighteen clones of Ishikawa cells. Hum Cell1996;9:109-116.
17.
17. Auffray C, Rougeon F.Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem1980;107:303-314.
18.
18. Blok LJ, Grossmann ME, Perry JE, Tindall DJ. Characterization of an early growth response gene, which encodes a zinc finger transcription factor, potentially involved in cell cycle regulation. Mol Endocrinol1995;9:1610-1620.
19.
19. Zava DT, Landrum B, Horwitz KB, McGuire WL. Androgen receptor assay with [3H]methyltrienolone (R1881) in the presence of progesterone receptors. Endocrinology1979;104:1007-1012.
20.
20. Darzynkiewicz Z, Li X, Gong J.Assays of cell viability: discrimination of cells dying by apoptosis. Methods Cell Biol1994; 41:15-38.
21.
21. Shen T, Horwitz KB, Lange CA. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of senine 294. Mol Cell Biol2001;21:6122-6131.
22.
22. Hanekamp EE, Gielen SCJP, Smid-Koopman E, et al. Concequences of loss of progesterone receptor expression in development of metastatic endometrial cancer. Clin Cancer Res2003; 9:4190-4199.
23.
23. Mote PA, Balleine RL, McGowan EM, Clarke CL. Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle. J Clin Endocrinol Metab1999;84;2963-2971.
24.
24. Shyamala G, Yang X, Silberstein G, Barcellos-Hoff MH, Dale E. Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. Proc Natl Acad Sci USA1998;95:696-701.
25.
25. Mulac-Jenicevic B, Mullinax RA, DeMayo FJ, Lydon JP, Conneely OM. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science2000; 289:1751-1754.
26.
26. De Vivo I, Huggins GS, Hankinson SE, et al. A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk. Proc Natl Acad Sci USA2002;99:12263-12268.
27.
27. Fujimoto J, Ichigo S, Hori M, Nishigaki M, Tamaya T.Expression of progesterone receptor form A and B mRNAs in gynecologic malignant tumors. Tumour Biol1995;16:254-260.
28.
28. Fujimoto J, Ichigo S, Hirose R, Sakaguchi H, Tamaya T.Clinical implication of expression of progesterone receptor form A and B mRNAs in secondary spreading of gynecologic cancers. J Steroid Biochem Mol Biol1997;62:449-454.
29.
29. Arnett-Mansfield RL, deFazio A, Wain GV, et al. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium. Cancer Res2001;61:4576-4582.
30.
30. Sasaki M, Dharya A, Oh BR, Tanaka Y, Fujimoto S, Dahiya R.Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer. Cancer Res2001;61:97-102.
31.
31. Misao R, Nakanishi Y, Sun W, Iwagaki S, Fujimoto J, Tamaya T. Identification of exon-deleted progesterone receptor mRNAs in human uterine endometnral cancers. Oncology2000;58:60-65.
32.
32. Dai D, Kumar NS, Wolf DM, Leslie KK. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation. Am J Obstet Gynecol2001;184:790-797.
33.
33. Dai D, Wolf DM, Litman ES, White MJ, Leslie KK. Progesterone inhibits human endometrial cancer cell growth and invasiveness: Down-regulation of cellular adhesion molecules through progesterone B receptors. Cancer Res2002;3:881-886.
34.
34. Conneely OM, Lydon JP. Progesterone receptors in reproduction: Functional impact of the A and B isoforms. Steroids2000;65:571-577.
35.
35. Conneely OM, Mulac-Jericevic B, Lydon JP, De Mayo FJ. Reproductive functions of the progesterone receptor isoforms: Lessons from knock-out mice. Mol Cell Endocrinol2001; 179:97-103.
36.
36. Li X, O'Malley BW. Unfolding the action of progesterone receptors. J Biol Chem2003;278:39261-39264.
37.
37. Weaver VM, Lehevre S, Lakins JN, et al. Beta4 integnrn-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell2002;2:205-216.
38.
38. Collard TJ, Guy M, Butt AJ, et al. Transcriptional upregulation of the insulin-like growth factor binding protein IGFBP-3 by sodium butyrate increases IGF-independent apoptosis in human colonic adenoma-derived epithelial cells. Carcinogenesis2003; 24:393-401.
39.
39. Butcher HL, Kennette WA, Collins O, Zalups RK and Koropatnick J.Metallothionein mediates the level and activity of nuclear factor kb in murine fibroblasts. J Pharmacol Exp Ther2004; 310:589-598.
40.
40. Hurbin A, Dubrez L, Coll JL, Favrot MC. Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptordependent pathway in non-small cell lung cancer cell lines. Ann NY Acad Sci2003;1010:354-357.
